Holen Sie sich die Stockscreener-App
0.72
2.10%
0.0148
Handel nachbörslich:
.71
-0.01
-1.39%
Schlusskurs vom Vortag:
$0.7052
Offen:
$0.706233
24-Stunden-Volumen:
87,559
Relative Volume:
0.02
Marktkapitalisierung:
$5.36M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.28M
KGV:
-0.0518
EPS:
-13.91
Netto-Cashflow:
$-13.75M
1W Leistung:
+5.11%
1M Leistung:
-3.74%
6M Leistung:
-70.25%
1J Leistung:
-87.59%
1-Tages-Spanne:
$0.681
$0.7292
1-Wochen-Bereich:
$0.65
$0.735
52-Wochen-Spanne:
$0.65
$7.50
Pasithea Therapeutics Corp Stock (KTTA) Company Profile
Firmenname
Pasithea Therapeutics Corp
Sektor
Branche
Telefon
(702) 514-4174
Adresse
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH
Vergleichen Sie KTTA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KTTA
Pasithea Therapeutics Corp
|
0.72 | 5.10M | 0 | -16.28M | -13.75M | -13.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Pasithea Therapeutics Corp Aktie (KTTA) Neueste Nachrichten
Pasithea Therapeutics Corp. Stock Analysis and ForecastExplosive earnings growth - jammulinksnews.com
What drives Pasithea Therapeutics Corp. Equity Warrant stock priceFree Stock Market Forecast Reports - Autocar Professional
What analysts say about Pasithea Therapeutics Corp. Equity Warrant stockPowerful market insights - jammulinksnews.com
Pasithea Therapeutics Corp. Equity Warrant Stock Analysis and ForecastPhenomenal capital gains - jammulinksnews.com
What drives Pasithea Therapeutics Corp. stock priceDynamic portfolio growth - jammulinksnews.com
What analysts say about Pasithea Therapeutics Corp. stockRapid growth opportunities - jammulinksnews.com
What makes Pasithea Therapeutics Corp. Equity Warrant stock price move sharplyFree Exclusive Stock Market Insights - Newser
Is Pasithea Therapeutics Corp. Equity Warrant a good long term investmentHigh-yield growth strategies - jammulinksnews.com
Is Pasithea Therapeutics Corp. a good long term investmentConsistent high-yield stocks - jammulinksnews.com
Why Pasithea Therapeutics Corp. stock attracts strong analyst attentionROI Focused Stock Calls - Newser
How Pasithea Therapeutics Corp. Equity Warrant stock performs during market volatility200 Percent Gain Alert - Newser
How Pasithea Therapeutics Corp. stock performs during market volatilityAnalyst Grade Signals - Newser
Why Pasithea Therapeutics Corp. Equity Warrant stock attracts strong analyst attentionFree Smart Investment Opportunities - Newser
What makes Pasithea Therapeutics Corp. stock price move sharplyDaily Stock Radar - Newser
Pasithea Sets Deadline for Shareholder Proposals - The Globe and Mail
Finanzdaten der Pasithea Therapeutics Corp-Aktie (KTTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):